Skip to content
Thursday, February 9, 2023
Latest:
  • Fusion Pharmaceuticals Appoints Donald Bergstrom, M.D., Ph.D., to Board of Directors
  • SQI Diagnostics Submits RALI-Dx(TM) IL-6 Severity Triage Test for COVID-19 Patients to FDA for Emergency Use Authorization
  • MindMed Announces 2020 Year-End Financial Results; Current Cash Balance of $161 million USD ($203 million CAD) to Support Drug Development Pipeline and Creation of Psychedelic Medicine Tech Platform
  • Xinhua Silk Road: Nanjing Jiangbei New Area invites global partners to jointly promote dev. of life and health industry
  • Amgen announces Artificial Intelligence (AI) Partnership with Mila
Biotech Stock Market Report

Biotech Stock Market Report

Know First, Act First

  • Covid-19
  • General
  • Financing
  • Pharma
  • Global
  • Trending

BIOTCHNO

BIOTCHNO Pharma 

Fusion Pharmaceuticals Appoints Donald Bergstrom, M.D., Ph.D., to Board of Directors

May 24, 2021June 7, 2021 Raza

Canada NewsWire HAMILTON , ON and BOSTON , April 1, 2021 /CNW/ — Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company

Read more
BIOTCHNO Featured 

SQI Diagnostics Submits RALI-Dx(TM) IL-6 Severity Triage Test for COVID-19 Patients to FDA for Emergency Use Authorization

April 1, 2021August 4, 2021 RJ

Canada NewsWire Test Designed to Assist in Identifying Severe Inflammatory Response in Patients with Confirmed COVID-19 Illness TORONTO , April

Read more
BIOTCHNO Pharma 

MindMed Announces 2020 Year-End Financial Results; Current Cash Balance of $161 million USD ($203 million CAD) to Support Drug Development Pipeline and Creation of Psychedelic Medicine Tech Platform

March 30, 2021July 26, 2021 Raza

Canada NewsWire Net Cash Used in Operating Activities (Total Cash Burn) of $24.2 million USD ( $30.5 million CAD) for

Read more
BIOTCHNO General 

Xinhua Silk Road: Nanjing Jiangbei New Area invites global partners to jointly promote dev. of life and health industry

March 22, 2021June 2, 2021 Raza

Canada NewsWire BEIJING , March 22, 2021 /CNW/ — Nanjing Jiangbei New Area , a state-level new area in east

Read more
BIOTCHNO Trending 

Amgen announces Artificial Intelligence (AI) Partnership with Mila

March 16, 2021July 19, 2021 Raza

Canada NewsWire MONTREAL , March 16, 2021 /CNW/ – Amgen announced today that it has entered into a multi-year partnership

Read more
BIOTCHNO Global 

Debiopharm Grants a Worldwide Exclusive License to Merck KGaA, Darmstadt, Germany for the Development and Commercialization of Xevinapant

March 1, 2021May 17, 2021 Raza

Xevinapant is the first Inhibitor of Apoptosis Proteins antagonist with FDA Breakthrough Therapy Designation for previously untreated locally advanced squamous

Read more
BIOTCHNO General 

AmpliTech Group, Inc. Expands Board of Directors Announcing Second New Board Member

February 28, 2021April 8, 2021 vanessa

Bohemia, New York–(Newsfile Corp. – January 28, 2021) – AmpliTech Group, Inc. (OTCQB: AMPG) announced today that they have appointed

Read more
BIOTCHNO General 

UAT Group Acquires Boost Words, Inc.

February 23, 2021April 8, 2021 Bachittar

Tampa, Florida–(Newsfile Corp. – February 23, 2021) – Umbra Applied Technologies Group, Inc (OTC Pink: UATG) announced today that it

Read more
BIOTCHNO Financing 

AmpliTech Announces Closing of Upsized $9.6 Million Public Offering

February 19, 2021April 8, 2021 Bachittar

Bohemia, New York–(Newsfile Corp. – February 19, 2021) – AmpliTech Group, Inc. (NASDAQ: AMPG) (NASDAQ: AMPGW) (the “Company”), a designer,

Read more
BIOTCHNO Financing 

The Valens Company to Hold Conference Call to Discuss Financial Results for the Fourth Quarter and Fiscal Year 2020

February 18, 2021April 16, 2021 Bachittar

  Canada NewsWire KELOWNA, BC,Feb. 18, 2021/CNW/ –The Valens Company Inc.(TSX: VLNS) (OTCQX: VLNCF) (the“Company,” “The Valens Company” or“Valens”), a leading

Read more
  • ← Previous

Covid-19

ImmunoPrecise and LiteVax Advance SARS-CoV-2 Vaccine Candidate
BIOTCHNO Covid-19 

ImmunoPrecise and LiteVax Advance SARS-CoV-2 Vaccine Candidate

December 14, 2020April 16, 2021 vanessa

VICTORIA, BC,Dec. 14, 2020/CNW/ – IMMUNOPRECISE ANTIBODIES LTD. (“IPA”) (TSXV: IPA) (IPATD: IPA) (FSE: TQB), a leader in full-service, therapeutic antibody

LuminUltra Expands Testing Capacity Including Range of COVID-19 Offerings with Acquisition of Source Molecular Corporation
BIOTCHNO Covid-19 

LuminUltra Expands Testing Capacity Including Range of COVID-19 Offerings with Acquisition of Source Molecular Corporation

November 30, 2020April 16, 2021 vanessa
Aerovirus Technologies Inc. (AvT) of St-Hyacinthe is developing the first real-time virus detection device, Aerovirus-1, to fight COVID-19.
BIOTCHNO Covid-19 

Aerovirus Technologies Inc. (AvT) of St-Hyacinthe is developing the first real-time virus detection device, Aerovirus-1, to fight COVID-19.

November 26, 2020April 16, 2021 vanessa
  • Disclaimer
  • Privacy Policy
TD Media LLC dba Life Water Media
1415 South Voss Road Suite 110-431 Houston, TX 77057